EverSource Wealth Advisors LLC Purchases 265 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

EverSource Wealth Advisors LLC boosted its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 10.1% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 2,887 shares of the healthcare conglomerate’s stock after purchasing an additional 265 shares during the period. EverSource Wealth Advisors LLC’s holdings in UnitedHealth Group were worth $1,688,000 at the end of the most recent quarter.

Several other institutional investors have also recently added to or reduced their stakes in the company. Price T Rowe Associates Inc. MD raised its stake in shares of UnitedHealth Group by 0.4% in the first quarter. Price T Rowe Associates Inc. MD now owns 26,062,928 shares of the healthcare conglomerate’s stock worth $12,893,331,000 after acquiring an additional 94,641 shares during the last quarter. Bank of New York Mellon Corp raised its stake in shares of UnitedHealth Group by 0.4% in the second quarter. Bank of New York Mellon Corp now owns 8,039,601 shares of the healthcare conglomerate’s stock worth $4,094,247,000 after acquiring an additional 35,533 shares during the last quarter. International Assets Investment Management LLC raised its stake in shares of UnitedHealth Group by 78,814.4% in the third quarter. International Assets Investment Management LLC now owns 5,296,737 shares of the healthcare conglomerate’s stock worth $3,096,896,000 after acquiring an additional 5,290,025 shares during the last quarter. Dimensional Fund Advisors LP raised its stake in shares of UnitedHealth Group by 30.0% in the second quarter. Dimensional Fund Advisors LP now owns 3,816,254 shares of the healthcare conglomerate’s stock worth $1,942,956,000 after acquiring an additional 880,183 shares during the last quarter. Finally, Ameriprise Financial Inc. grew its position in shares of UnitedHealth Group by 0.6% during the 2nd quarter. Ameriprise Financial Inc. now owns 3,772,487 shares of the healthcare conglomerate’s stock worth $1,920,039,000 after buying an additional 21,149 shares during the period. 87.86% of the stock is owned by institutional investors.

UnitedHealth Group Price Performance

NYSE:UNH opened at $600.50 on Thursday. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $630.73. The company has a market cap of $552.63 billion, a P/E ratio of 39.12, a P/E/G ratio of 1.69 and a beta of 0.58. The firm’s fifty day moving average price is $582.52 and its two-hundred day moving average price is $551.60. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.91.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, topping the consensus estimate of $7.00 by $0.15. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The business had revenue of $100.82 billion during the quarter, compared to analysts’ expectations of $99.14 billion. During the same quarter in the previous year, the company earned $6.56 EPS. The business’s revenue was up 9.2% on a year-over-year basis. Equities analysts expect that UnitedHealth Group Incorporated will post 27.6 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th will be issued a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.40%. The ex-dividend date is Monday, December 9th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 54.72%.

Analysts Set New Price Targets

Several equities research analysts have recently commented on the stock. KeyCorp assumed coverage on shares of UnitedHealth Group in a research report on Friday, October 11th. They set an “overweight” rating and a $675.00 price target for the company. Truist Financial restated a “buy” rating and set a $625.00 price objective (down previously from $640.00) on shares of UnitedHealth Group in a report on Wednesday, October 16th. Stephens decreased their price objective on shares of UnitedHealth Group from $632.00 to $605.00 and set an “overweight” rating for the company in a report on Wednesday, October 16th. Morgan Stanley decreased their price objective on shares of UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating for the company in a report on Wednesday, October 16th. Finally, Bank of America decreased their price objective on shares of UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating for the company in a report on Wednesday, October 16th. Four equities research analysts have rated the stock with a hold rating, seventeen have issued a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $615.53.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.